Practice-changing data in endometrial cancer support checkpoint inhibitor–chemotherapy combinations, extending ...

PAGADIAN CITY, Zamboanga del Sur – Ten members of the Society of Gynecologic Oncologists of the Philippines Foundation, Inc. ...

Gynecologic cancers affect thousands of women each year, yet many remain difficult to detect in their earliest stages.

In this video, Rebecca Stone, MD, MS, discussed highlights in ovarian cancer from Society of Gynecologic Oncology 2026 Winter ...

Detailed price information for Citius Pharmaceuticals Inc (CTXR-Q) from The Globe and Mail including charting and trades.

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology‑focused biopharmaceutical company and majority‑owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), ...

Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...

Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...

An Omaha woman diagnosed with endometrial cancer days before her 43rd birthday is now partnering with her oncologist to raise awareness about a disease she says too many women are embarrassed to ...

"I dismissed my fear as paranoia. But, deep down, I still felt that something was wrong." ...

Doctors in all specialties need more education on menopause and hormone therapy so that they don't give women conflicting recommendations, several speakers said here Friday at the HHS National ...

Tampa General Hospital 2nd in the world to receive Center of Excellence in Women's Integrated Surgical Health designation from Surgical Review Corp.